Catalog |
name |
Description |
price |
R-M1-8506 |
Heparin-PEG-PBA |
Heparin-PEG-PBA,heparin-PEG-Phenylboronic acid is a conjugated molecule that combines the anticoagulant properties of heparin with the sugar-binding capabilities of phenylboronic acid, expanding its potential applications in the field of biomedical research and therapeutics. |
price> |
R-M1-8571 |
Cholesterol-PEG2K-Gemcitabine |
Cholesterol-PEG2K-Gemcitabine refers to a specific conjugate molecule involving the attachment of gemcitabine, a chemotherapy drug used to treat various cancers, to a cholesterol derivative that is connected to a polyethylene glycol (PEG) spacer.
This cholesterol-PEG2K-gemcitabine conjugate is designed to improve the solubility, stability, and targeted delivery of gemcitabine, potentially increasing its effectiveness in cancer treatment while minimizing adverse side effects. The specific PEG spacer length and cholesterol modification may vary depending on the intended application and desired properties of the conjugate. |
price> |
R-M1-8602 |
Tetrazine-PEG7-DOTA |
Tetrazine-PEG7-DOTA/Tetrazine-PEG7-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid/Tetrazine-PEG7-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid provides a versatile tool for the construction of targeted imaging agents or therapeutics with improved properties and selectivity for biological applications. |
price> |
R-M1-8636 |
DMG PEG2000 Azide |
DMG-PEG2K-N3/1,2-dimyristoyl-rac-glycero-3-polyethylene glycol-PEG2K-N3/DMG-PEG2000-N3/ Azide PEG2000 DMG/1,2-dimyristoyl-rac-glycero-3-polyethylene glycol 2000 Azide has been used as molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. |
price> |
R-M1-8640 |
DMG-PEG2000-4-Dimethylamino Butyric Acid |
The combination of DMG, PEG2000, and 4-Dimethylamino Butyric Acid(DMG-PEG2000-4-Dimethylamino Butyric Acid/DMG-PEG2000-DMBA/DMG-PEG2000-4-(dimethylamino)butyric acid (DMBA)/1,2-Dimyristoyl-sn-glycerol-PEG2000-4-(dimethylamino)butyric acid)allows for modifications, functionalizations, or conjugations of biomolecules or surfaces. This can be useful for enhancing solubility, biocompatibility, or as a linker for attaching other molecules or drugs. The specific application or purpose of DMG-PEG2000-4-Dimethylamino Butyric Acid would depend on the research or experimental requirements.4- (Dimethylamino) butyric acid (DMBA) can be expanded into alloy nanoparticles for electrochemical luminescence. |
price> |
R-M1-8643 |
DMG-PEG2000-α-GalNAc |
DMG-PEG2000-α-GalNAc/DMG-PEG2000-alpha-N-acetylgalactosamine/1,2-dimyristoyl-rac-glycero-3-PEG2000-alpha-N-acetylgalactosamine/1,2-dimyristoyl-rac-glycero-3-PEG2000-α-GalNAc have targeted drug delivery, surface modification for enhanced biocompatibility, or facilitating specific cellular interactions. |
price> |
R-M1-8698 |
Retinol-PEG2000-(3-Mercaptopropionic acid) |
Retinol-PEG2000-3-Mercaptopropionic acid might offer several potential advantages, such as increased solubility of retinol, better pharmacokinetic profile, and attachment points for other functional groups or biomolecules. This conjugate could be used in drug delivery or targeted therapy, as well as in the development of novel retinol-based formulations for various biomedical applications. |
price> |
R-M1-8731 |
DMG-PEG2000-GALA |
DMG-PEG2000-Galactose/1,2-Dimyristoyl-sn-glycerol-methoxypolyethylene glycol2000-Galactose/Galactose-PEG2000-DMG/1,2-Dimyristoyl-sn-glycerolPEG2000-Galactose is a compound that combines the benefits of DMG and PEG with the targeting capabilities of galactose. This conjugate has potential applications in targeted drug delivery, where it specifically recognizes and binds to cells expressing galactose receptors, such as liver cells or certain types of cancer cells, improving the delivery of therapeutic agents to these cells. |
price> |
R-M1-8738 |
N3-PEG2K-CE6 |
Azide-PEG2K-chlorin e6/N3-PEG2K-chlorin e6/CE6-PEG2K-N3/Chlorin e6-PEG2K-N3/N3-PEG2K-CE6 combines the azide-alkyne click chemistry, the versatile properties of PEG, and the photodynamic therapy capabilities of CE6 to enable specific delivery and targeted photodynamic therapy applications in biomedical research and clinical settings. |
price> |